ARNALDI, Giorgio
 Distribuzione geografica
Continente #
NA - Nord America 5.548
EU - Europa 2.899
AS - Asia 1.199
SA - Sud America 262
AF - Africa 61
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 9.979
Nazione #
US - Stati Uniti d'America 5.537
UA - Ucraina 512
IT - Italia 437
RU - Federazione Russa 420
IE - Irlanda 417
SG - Singapore 399
SE - Svezia 320
CN - Cina 288
HK - Hong Kong 261
DE - Germania 253
BR - Brasile 242
GB - Regno Unito 145
DK - Danimarca 143
TR - Turchia 110
FI - Finlandia 99
FR - Francia 76
KR - Corea 71
CI - Costa d'Avorio 41
BE - Belgio 30
IN - India 22
NL - Olanda 11
IR - Iran 10
MA - Marocco 10
AT - Austria 7
CA - Canada 7
CZ - Repubblica Ceca 7
LT - Lituania 7
AR - Argentina 6
EC - Ecuador 6
IQ - Iraq 6
JP - Giappone 5
AU - Australia 4
EG - Egitto 4
EU - Europa 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
ES - Italia 3
JO - Giordania 3
UZ - Uzbekistan 3
VN - Vietnam 3
AM - Armenia 2
CO - Colombia 2
JM - Giamaica 2
NZ - Nuova Zelanda 2
OM - Oman 2
PT - Portogallo 2
TH - Thailandia 2
ZA - Sudafrica 2
AZ - Azerbaigian 1
BD - Bangladesh 1
BG - Bulgaria 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
CL - Cile 1
DZ - Algeria 1
GE - Georgia 1
GR - Grecia 1
IL - Israele 1
IS - Islanda 1
KE - Kenya 1
LB - Libano 1
MX - Messico 1
NO - Norvegia 1
NP - Nepal 1
PE - Perù 1
PK - Pakistan 1
PL - Polonia 1
PS - Palestinian Territory 1
PY - Paraguay 1
QA - Qatar 1
TN - Tunisia 1
UY - Uruguay 1
VE - Venezuela 1
Totale 9.979
Città #
Chandler 677
Jacksonville 672
Des Moines 457
Fairfield 425
Dublin 417
Boardman 358
Ashburn 321
Hong Kong 261
Wilmington 219
Woodbridge 191
Singapore 190
New York 184
Seattle 176
Ann Arbor 162
Lawrence 161
Princeton 161
San Mateo 151
Houston 136
Cambridge 128
Moscow 97
Centro 93
The Dalles 78
San Diego 55
Abidjan 41
Turin 38
Helsinki 31
Shanghai 30
Los Angeles 29
Brussels 28
London 28
Beijing 25
Washington 24
Guangzhou 23
Norwalk 21
São Paulo 21
Dallas 20
Pune 19
Civitanova Marche 16
Rome 16
Wuhan 14
New Bedfont 13
Ancona 12
Belo Horizonte 11
Wuxi 11
Falls Church 10
Kilburn 10
Rio de Janeiro 10
Ascoli Piceno 9
Jinhua 9
Nuremberg 9
Pescara 9
Redmond 9
Santa Clara 9
Yiwu 9
Chiswick 7
Karaj 7
Olomouc 7
Brooklyn 6
Curitiba 6
Milan 6
San Francisco 6
Baghdad 5
Brasília 5
Camerino 5
Goiânia 5
Heze 5
Marche 5
Porto Alegre 5
Senigallia 5
Shenzhen 5
Tokyo 5
Vallefoglia 5
Altenmarkt im Pongau 4
Auburn Hills 4
Campinas 4
Caxias do Sul 4
Chicago 4
Guayaquil 4
Istia D'ombrone 4
Ivrea 4
Jiaxing 4
Macerata 4
Naples 4
Ravenna 4
San Jose 4
Seoul 4
Sorocaba 4
Amman 3
Avellino 3
Bauru 3
Brugherio 3
Como 3
Council Bluffs 3
Fayetteville 3
Filottrano 3
Florence 3
Fortaleza 3
Grumo Nevano 3
Hanover 3
Hounslow 3
Totale 6.533
Nome #
Isolation and characterization of progenitor mesenchymal cells in human pituitary tumors. 131
ISOLATION AND CHARACTERIZATION OF MESENCHYMAL CELLS FROM PITUITARY TUMOURS 125
Impact of COVID-19 pandemic on psychophysical stress in patients with adrenal insufficiency: the CORTI-COVID study 122
Age-related modifications of the human growth hormone circadian secretory pattern studied with a new statistical method in healthy adults 110
Pituitary adenomas, stem cells, and cancer stem cells: what's new? 110
Adrenal incidentaloma: surgical update. 109
Cushing Syndrome: The Role of MSCs in Wound Healing, Immunosuppression, Comorbidities, and Antioxidant Imbalance 106
Human corticotropin releasing hormone test performance in the differential diagnosis between Cushing's disease and pseudo-Cushing state is enhanced by combined ACTH and cortisol analysis. 103
Desmopressin test in the differential diagnosis of Pseudo-Cushing state from Cushing’s disease. 102
Effects of long-term treatment with human pure FSH on seminal parameters and sperm cells ultrastructure in idiopathic oligo-asthenozoospermia. 102
Qualità della vita nei pazienti con sindrome adrenogenitale ed impatto della terapia sostitutiva. 100
Ruolo dell’osmolarità seminale nella regolazione della motilità degli spermatozoi nell’uomo 99
ACROSCORE: a new and simple tool for the diagnosis of acromegaly, a rare and underdiagnosed disease. 98
The diagnostic accuracy of increased late night salivary cortisol for Cushing's syndrome: a real-life prospective study 97
RNA sequencing and somatic mutation status of adrenocortical tumors: novel pathogenetic insights 96
COVID-19 infection and glucocorticoids: update from the Italian Society of Endocrinology Expert Opinion on steroid replacement in adrenal insufficiency 94
Diagnosis and complications of Cushing's syndrome: a consensus statement 93
Importance of sleep and melatonin for the human prolactin circadian secretory pattern in normal and pathological conditions 91
Bone complications in patients with Cushing's syndrome: looking for clinical, biochemical, and genetic determinants. 91
Unusual clinical manifestation of pheochromocytoma in a MEN2A patient 88
AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing's syndrome 88
The medical treatment with pasireotide in Cushing’s disease: an Italian multicentre experience based on “real-world evidence” 88
High-dose and high-frequency lanreotide autogel in acromegaly: A randomized, multicenter study 87
Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications. 86
Echo Doppler in the characterization of thyroid nodular disease 85
Decreased expression of insulin-sensitive glucose transporter mRNA (GLUT-4) in adipose tissue of non-insulin-dependent diabetic and obese patients: evaluation by a simplified quantitative PCR assay. 85
Body composition and metabolic features in women with adrenal incidentaloma or Cushing's syndrome. 85
Effects of somatostatin and its analogues on progenitor mesenchymal cells isolated from human pituitary adenomas 83
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment 83
How to improve effectiveness of pegvisomant treatment in acromegalic patients 83
Changes in adenosine 5'-monophosphate-activated protein kinase as a mechanism of visceral obesity in Cushing's syndrome. 80
Self image and quality of life in acromegaly 79
ENSAT registry-based randomized clinical trials for adrenocortical carcinoma 79
Safety and effectiveness of Omnitrope® in patients with growth hormone deficiency: snapshot analysis of PATRO Adults study in the Italian population 78
Analisys of Y-linked microdeletions in idiopathic oligo- and azoospermic patients 77
Towards the tailoring of glucocorticoid replacement in adrenal insufficiency: the Italian Society of Endocrinology Expert Opinion 77
Determinazione comparativa dei livelli del coenzima Q10 nelle oligozoospermie idiopatiche e nel varicocele 75
High cardiovascular risk in patients with Cushing's syndrome accorìging to 1999 WHO/ISH guidelines 75
Primary adrenal hypercortisolism: minimally invasive surgical treatment or medical therapy? A retrospective study with long-term follow-up evaluation. 75
Use of the desmopressin test in the differential diagnosis of pseudo-Cushing state from Cushing's disease 74
A novel endothelial tyrosine kinase cDNA homologous to platelet-derived growth factor receptor cDNA. 74
Corticotropin-releasing hormone and desmopressin tests in the differential diagnosis between Cushing's disease and Pseudo-Cushing state: a comparative study. 74
Cyclical Cushing's syndrome in a patient with a bronchial neuroendocrine tumor (typical carcinoid) expressing ghrelin and growth hormone secretagogue receptors. 74
Glucocorticoid excess and COVID-19 disease 74
ADRENAL MORPHO-FUNCTIONAL ALTERATIONS IN PATIENTS WITH ACROMEGALY. 72
Pituitary adenoma apoplexy: Review of personal series. 72
Somatic PRKACA Mutations: Association With Transition From Pituitary-Dependent to Adrenal-Dependent Cushing Syndrome 71
Androgens in Cushing's Syndrome 71
New treatment guidelines on Cushing's disease. 70
The role of an acute pasireotide suppression test in predicting response to treatment in patients with Cushing’s disease: findings from a pilot study 70
Diagnostic accuracy of increased urinary cortisol/cortisone ratio to differentiate ACTH-dependent Cushing's syndrome 70
Coenzyme Q10 levels in idiopathic and varicocele-associated asthenozoospermia 69
A Single-Center 10-Year Experience with Pasireotide in Cushing's Disease: Patients' Characteristics and Outcome. 69
An evaluation of the ultrastructural features improvement in idiopathic oligo-astenospermia after FSH treatment 69
Semen osmolarity and sperm motility 69
Acromegaly Is More Severe in Patients With AHR or AIP Gene Variants Living in Highly Polluted Areas 68
Association of glucocorticoid receptor polymorphism A3669G with decreased risk of developing diabetes in patients with Cushing's syndrome 68
Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM) 67
Mitotane concentrations influence outcome in patients with advanced adrenocortical carcinoma 67
Hypothalamic-Pituitary Diseases and Erectile Dysfunction 67
Acromegaly and male sexual health 66
Expression of growth hormone-releasing hormone receptor splicing variants in human primary adrenocortical tumours 66
Enhanced expression of transforming growth factor beta 1 in rat thyroid hyperplasia is thyrotropin induced and time dependent 66
A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype 66
Mesenchymal Stem Cells Exposed to Persistently High Glucocorticoid Levels Develop Insulin-Resistance and Altered Lipolysis: A Promising In Vitro Model to Study Cushing’s Syndrome 66
Fine-needle aspiration cytology of adrenal masses: a re-assessment with histological confirmation. 65
Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial 65
Sexual Dysfunctions in Men Affected by Autoimmune Addison's Disease Before and After Short-Term Gluco- and Mineralocorticoid Replacement Therapy 64
Adrenal incidentaloma. 64
Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: A multicenter study 64
Harmful effects of functional hypercortisolism: a working hypothesis. 64
Long-term treatment of Cushing’s disease with pasireotide: 5-year results from an open-label extension study of a Phase III trial 64
Analysis of GRP101 and AIP genes mutations in acromegaly: a multicentre study 62
Is pasireotide-induced diabetes mellitus predictable? A pilot study on the effect of a single dose of pasireotide on glucose homeostasis 62
Reduced expression of the growth hormone and type 1 insulin-like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptor. 61
Telomerase activity is significantly enhanced in malignant adrenocortical tumors in comparison to benign adrenocortical adenomas. 61
Isolation and characterization of Mesenchymal Stem Cells from pituitary tumours 60
Cardiovascular risk in Cushing's syndrome. 60
ACTH receptor mRNA in human adrenocortical tumors: overexpression in aldosteronomas. 59
Adrenal incidentaloma: an overview of hormonal data from the National Italian Study Group. 59
High cardiovascular risk in patients with Cushing's syndrome according to 1999 WHO/ISH guidelines. 59
Advances in medical treatment of Cushing’s disease 58
Salivary cortisol is a useful tool to assess the early response to pasireotide in patients with Cushing's disease. 58
Protective role of ubiquinol-10 against peroxidation in human seminal fluid plasma 58
Adrenal incidentaloma. 57
Impatto della terapia sostitutiva sulla qualità della vita nei pazienti con iperplasia surrenalica congenita. 57
Hypertension-induced changes of platelet-derived growth factor receptor expression in rat aorta and heart. 56
Coagulopathy in Cushing's syndrome. 56
Histological contamination in clinical research: from ultrastrcture to stem cel biology. 56
Severe hypomagnesemia-induced hypocalcemia in a patient with Gitelman’s sindrome 55
Decreased resistance to toxicity of reactive oxygen species in seminal plasma of asthenospermic individuals 54
Treatment-related fatigue with sorafenib, sunitinib and pazopanib in patients with advanced solid tumors: an up-to-date review and meta-analysis of clinical trials 53
[Cytological diagnosis of thyroid nodules. Comparison of results obtained with guided echography with those from of a "blind" biopsy]. 53
Pituitary-directed medical treatment of Cushing’s disease. 53
Conventional and nuclear medicine imaging in Ectopic Cushing's syndrome: A systematic review 53
COVID-19 and endocrine and metabolic disorders: critical points and suggestions for a correct therapeutic management from a tertiary endocrine center in Italy 53
Potential indications for somatostatin analogs in Cushing's syndrome. 52
Approach to the patient with possible Cushing's syndrome 49
Effects of exogenous CoQ10 administration in patients with idiopathic asthenozoospermia 49
CoQ10 dietary implementation in patients with idiopathic asthenozoospermia 48
Totale 7.445
Categoria #
all - tutte 64.734
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.734


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020271 0 0 0 0 0 0 0 0 0 0 85 186
2020/20211.942 86 200 249 30 208 93 227 183 218 148 200 100
2021/20221.137 60 225 29 68 7 77 41 90 80 101 101 258
2022/20232.311 210 232 165 174 108 609 6 103 525 11 120 48
2023/20241.357 236 45 120 178 214 272 38 31 7 40 21 155
2024/20251.996 324 225 81 28 66 56 284 92 524 179 137 0
Totale 10.203